Substance Abuse: Research and Treatment
Synopsis: An open access, peer reviewed electronic journal that covers all aspects of human substance abuse research and treatment.
Indexing: 7 major databases. Pubmed indexing for NIH-funded research.
Processing time: Decision in 2 weeks for 90% of papers.
Visibility: Most popular article read 900+ times.
About this journal
Aims and scope:
Substance Abuse: Research and Treatment is an international, open access, peer reviewed journal which considers manuscripts on all areas of human substance abuse research and treatment. These areas include: medical treatment and screening; mental health services; research; and evaluation of substance abuse programs.Editorial standards and procedures:
Submissions, excluding editorials, letters to the editor and dedications, will be peer reviewed by two reviewers. Reviewers are required to provide fair, balanced and constructive reports.
Under our Fairness in Peer Review Policy authors may appeal against reviewers' recommendations which are ill-founded, unobjective or unfair. Appeals are considered by the Editor in Chief or Associate Editor.
Papers are not sent to peer reviewers following submission of a revised manuscript. Editorial decisions on re-submitted papers are based on the author's response to the initial peer review report.
Indexing:
This journal is indexed by the following services:
- Google Scholar
- CAS
- SCOPUS
- Embase
- EMCare
- DOAJ
- OAIster
National Institutes of Health Public Access Policy compliant:
As of April 7 2008, the US NIH Public Access Policy requires that all peer reviewed articles resulting from research carried out with NIH funding be deposited in the Pubmed Central archive.
If you are an NIH employee or grantee Libertas Academica will ensure that you comply with the policy by depositing your paper at Pubmed Central on your behalf.
Call for papers:
Read the Editor in Chief's latest call for papers here.
Submission types accepted:
Submissions of the following types of manuscripts are accepted:
- Original research articles.
- Reviews: comprehensive, authoritative, descriptions of any subject within the journal's scope. They may cover basic science and clinical reviews, ethics, pro/con debates, and equipment reviews.
- Commentaries: focused and opinionated articles on any subject within the journal's scope. These articles are usually related to a contemporary issue.
- Hypotheses: articles that present an original hypothesis backed solely by previously published results rather than any new evidence. They should outline significant progress in thinking that would also be testable.
- Letters to the Editor: these can be either a re-analysis of a previously published article, or a response to such a re-analysis from the authors of the original publication.
- Methodology articles: these discuss a new experimental method, test or procedure. The article must describe a demonstrable advance on what is currently available. The method needs to have been well tested and ideally, but not necessarily, used in a way that proves its value.
- Short reports: brief reports of data from original research.
- Meeting reports: a report pertaining to activity at a meeting or conference Articles published in this journal are immediately available without delay upon publication and enjoy substantial visibility.
- Case reports: reports of clinical cases that can be educational, describe a diagnostic or therapeutic dilemma, suggest an association, or present an important adverse reaction. Case reports must meet appropriate ethical standards.
All submissions are subject to prompt, objective and fair peer review in compliance with our Fairness in Peer Review Policy. Copyright in published articles remains with the author(s). Authors are continually informed of the progress of their paper and our staff are friendly and responsive.
One author recently wrote: "I would like to say that this is the most author-friendly editing process I have experienced in over 150 publications. Thank you most sincerely."
Criteria for publication:
Publication is dependent on peer reviewers' judgement of papers. Reviewers are asked to provide thoughtful and unbiased feedback to authors to ensure that the conclusions of papers are valid and manuscripts achieve reasonable standards of scholarliness and intelligibility.
Previous work in the field must be acknowledged and papers should read without unreasonable difficulty. Papers should fit comfortably within the scope of the journal.
Reviewers are asked to act in a fair, objective and constructive manner which maintains quality standards and helps authors to communicate their research. They are instructed that in areas of genuinely novel research issues may be raised which cannot immediately be resolved and that absolutely rigorous validation of data may therefore not be possible.
More information on the role of peer reviewers is available on the information for reviewers page. Where authors consider that reviewers have made recommendations which are unreasonable, unobjective or ill-founded they may appeal them to the Editor in Chief or Associate Editor under our Fairness in Peer Review Policy.
Articles submitted to other journals:
We are willing to consider papers which have been peer reviewed by other journals but not accepted for publication.
Services for authors:
Prior to peer review of your paper we can:
- Have your paper's reference style revised to meet our requirements,
- Have your paper's English revised by specialist English-speaking technical editors.
After peer review of your paper we can:
- Have your paper revised in accordance with peer reviewer's recommendations and have a summary of responses to the reviewers created by our specialist external substantive editors,
- Provide bound reprints of your article in colour or black and white ,
- Provide online-early rapid publication if your paper prior to typesetting.
What other authors have said:
Libertas Academica actively requests, receives and acts upon feedback from authors, readers and editorial boards. Here's what some recent authors have said about us:
"Within a couple of days the reviewers had been procured and the manuscript was out."
"The communication between your staff and me has been terrific. Whenever progress is made with the manuscript, I receive notice. Quite honestly, I've never had such complete communication with a journal."
"LA is different, and hopefully represents a kind of scientific publication machinery that removes the hurdles from free flow of scientific thought."
Article processing fees:
All submissions to this journal are subject to an article processing fee if they are accepted for publication. Article processing fees are used to fund the processing of your paper and development of the journal. Article processing fees are the only compulsory charge you will face and do not vary according to word count, page count, colour figures or any other factor. There is no additional charge for the author(s) to make any use of their article and no charge to readers to access it.
Full fee waivers are available for authors working in undeveloped nations and partial discounts of 20-50% are available to authors in other nations. Authors must be able to verifiably demonstrate their suitability for a discount or waiver. Availability of waivers and discounts is subject to monthly availability and is given at the publisher's discretion. Waivers and discounts must be applied for prior to submission. Neither are available after submission.
Register as a peer reviewer:
Do you wish to register as a peer reviewer? Or are you already a registered peer reviewer but you need to update your contact details? To register or update your details visit the peer reviewer registration form.
Applicants must be able to demonstrate at least five years of continuous experience in the journal's subject area including at least two in the previous 24 months.
Journal newsletter sent to subscribers in week 36, 2009. Register to receive future newsletters.
Journal newsletter sent to subscribers in week 30, 2009. Register to receive future newsletters.
Read the Editor in Chief's latest call for papers here.
Journal newsletter sent to subscribers in week 19, 2009. Register to receive future newsletters.
Journal newsletter sent to subscribers in week 13, 2009. Register to receive future newsletters.
Journal newsletter sent to subscribers in week 12, 2009. Register to receive future newsletters.
This journal has been accepted for indexing in DOAJ.
Journal newsletter sent to subscribers in week 9, 2009. Register to receive future newsletters.
Journal newsletter sent to subscribers in week 8, 2009. Register to receive future newsletters.
Peer reviewers are sought. Click here to apply or to update your details.
Read about the new Editor in Chief and Associate Editor and read an interview with the Editor in Chief.
This journal has been accepted for indexing by Elsevier's highly regarded SCOPUS index
Hepatitis Infection in the Treatment of Opioid Dependence and Abuse
Thomas F. Kresina1, Diana Sylvestre2, Leonard Seeff3, Alain H. Litwin4, Kenneth Hoffman1, Robert Lubran1 and H. Westley Clark1
1Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration, Rockville, MD. 2Department of Medicine, University of California, San Francisco and Organization to Achieve Solutions In Substance Abuse (O.A.S.I.S.) Oakland, CA. 3Division of Digestive Diseases and Nutrition, National Institute on Diabetes, Digestive, and Kidney Diseases, National Institutes of Health, DHHS, Bethesda, MD. 4Division of Substance Abuse, Albert Einstein College of Medicine, Montefiore Medical Center Bronx, NY.
Abstract
Many new and existing cases of viral hepatitis infections are related to injection drug use. Transmission of these infections can result directly from the use of injection equipment that is contaminated with blood containing the hepatitis B or C virus or through sexual contact with an infected individual. In the latter case, drug use can indirectly contribute to hepatitis transmission through the dis-inhibited at-risk behavior, that is, unprotected sex with an infected partner. Individuals who inject drugs are at-risk for infection from different hepatitis viruses, hepatitis A, B, or C. Those with chronic hepatitis B virus infection also face additional risk should they become co-infected with hepatitis D virus. Protection from the transmission of hepatitis viruses A and B is best achieved by vaccination. For those with a history of or who currently inject drugs, the medical management of viral hepatitis infection comprising screening, testing, counseling and providing care and treatment is evolving. Components of the medical management of hepatitis infection, for persons considering, initiating, or receiving pharmacologic therapy for opioid addiction include: testing for hepatitis B and C infections; education and counseling regarding at-risk behavior and hepatitis transmission, acute and chronic hepatitis infection, liver disease and its care and treatment; vaccination against hepatitis A and B infection; and integrative primary care as part of the comprehensive treatment approach for recovery from opioid abuse and dependence. In addition, participation in a peer support group as part of integrated medical care enhances treatment outcomes. Liver disease is highly prevalent in patient populations seeking recovery from opioid addiction or who are currently receiving pharmacotherapy for opioid addiction. Pharmacotherapy for opioid addiction is not a contraindication to evaluation, care, or treatment of liver disease due to hepatitis virus infection. Successful pharmacotherapy for opioid addiction stabilizes patients and improves patient compliance to care and treatment regimens as well as promotes good patient outcomes. Implementation and integration of effective hepatitis prevention programs, care programs, and treatment regimens in concert with the pharmacological therapy of opioid addiction can reduce the public health burdens of hepatitis and injection drug use.
Comprehensive resources for those looking for recovery from addiction. http://addictionrecovery.net
Addiction treatment and recovery resources for the addict and their families. http://www.addictiontreatment.net
Readers of this also read:
- Hepatitis Infection in the Treatment of Opioid Dependence and Abuse
- Prescription Opioid Usage and Abuse Relationships: An Evaluation of State Prescription Drug Monitoring Program Efficacy
- How Long Does Craving Predict Use of Methamphetamine? Assessment of Use One to Seven Weeks After the Assessment of Craving
- Mammoth and Elephant Phylogenetic Relationships: Mammut Americanum, the Missing Outgroup
- Systems Biology-Based Identification of Crosstalk between E2F Transcription Factors and the Fanconi Anemia Pathway
- 31/Aug/2009
Prescription Opioid Usage and Abuse Relationships: An Evaluation of State Prescription Drug Monitoring Program Efficacy
- 01/May/2009
Carbon Nanotube Membranes for use in the Transdermal Treatment of Nicotine Addiction and Opioid Withdrawal Symptoms
- 18/Mar/2009
Examining the Interface Between Substance Misuse and Intimate Partner Violence
- 18/Feb/2009
The Influence of Web- Versus Paper-based Formats on the Assessment of Tobacco Dependence: Evaluating the Measurement Invariance of the Dimensions of Tobacco Dependence Scale
- 17/Feb/2009
At-Risk Drinking Among Diabetic Patients
- 20/Jan/2009
Study of arachidonic acid pathway in human bladder tumor (Provisional PDF)
- 01/Dec/2008
Nicotinic Receptors: Role in Addiction and other Disorders of the Brain
- 11/Nov/2008
Adolescent Suicidal Behavior and Substance Use: Developmental Mechanisms
- 31/Oct/2008
CNS Genes Implicated in Relapse
- 25/Sep/2008
How Long Does Craving Predict Use of Methamphetamine? Assessment of Use One to Seven Weeks After the Assessment of Craving
- 26/Aug/2008
Hepatitis Infection in the Treatment of Opioid Dependence and Abuse
- 28/Apr/2008
Feasibility of Ecological Momentary Assessment Using Cellular Telephones in Methamphetamine Dependent Subjects
- 10/Feb/2008
Comparing the Effects of Negative and Mixed Emotional Messages on Predicted Occasional Excessive Drinking
- 12/Jan/2008